Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
Casarosa C; Cosci di Coscio M; Fratta M
Division of Urology, Hospital Riuniti S. Chiara, Pisa, Italy.
Clin Ther 1988; 10 (5): 585-8
LANGUAGE OF PUBLICATION
Twenty men, aged 50 to 75 years (mean, 67 years), suffering from benign prostatic hypertrophy received 160 mg of a lyposterolic extract of Serenoa repens, twice daily for 30 days. Before and at the end of treatment, plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone were determined. No changes in plasma hormone levels occurred as a result of treatment. It is concluded that Serenoa extract, which is useful in the treatment of benign prostatic hypertrophy, does not act via systemic changes of hormone levels. (AUTHOR)
MJTR: FSH BL. LH BL. Plant Extracts PD. Plant Extracts TU. Prostatic Hyperplasia DT. Testosterone BL.
MNTR: Aged. Human. Male. Middle Age. Plants, Medicinal. Prostatic Hyperplasia BL. JOURNAL ARTICLE
RNUM: 0 (LG 166-S); 0 (Plant Extracts); 57-85-2 (Testosterone); 9002-67-9 (LH); 9002-68-0 (FSH)
GEOT: UNITED STATES
IDEN: ISSN: 0149-2918. JOURNAL-CODE: CPE. ENTRY-DATE: 930209. JOURNAL-SUBSET: M. IM-DATE: 9304.